Industry Research Reports and Market Analysis at MindBranch.com

Japan Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015

Published By: Global Markets Direct
May 2009
R3480-13928
Online Download   $2,500.00
Global Site License   $7,500.00
Description

Japan Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Japan cardiovascular devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the cardiovascular devices market in Japan

Scope
  • The report provides cardiovascular devices market information broken down into detailed categories and segments in Japan.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.
Reasons to buy
  • Gain a strong understanding of the cardiovascular devices market in Japan.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
Table of Contents
1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of Markets Covered in the Report
3.1 Cardiovascular Devices
3.2 Cardiac Rhythm Management
3.2.1 Cardiac Resynchronisation Therapy
3.2.1.1 Cardiac Resynchronisation Therapy - Defibrillator
3.2.1.2 Cardiac Resynchronisation Therapy - Pacemaker
3.2.2 Cardiovascular Pacing and ICD Leads
3.2.3 Implantable Cardioverter Defibrillator
3.2.3.1 Dual Chamber Implantable Cardioverter Defibrillator
3.2.3.2 Single Chamber Implantable Cardioverter Defibrillator
3.2.4 Pacemaker
3.2.4.1 Dual Chamber Pacemaker
3.2.4.2 Single Chamber Pacemaker
3.3 Cardiovascular Monitoring and Diagnostic Devices
3.3.1 ECG Monitoring Equipment
3.3.2 ECG Stress Testing Systems
3.3.3 Event Monitoring Systems
3.3.4 Holter Monitoring Systems
3.4 Cardiovascular Prosthetic Devices
3.4.1 Cardiac Assist Devices
3.4.1.1 Intra-Aortic Balloon Pump
3.4.1.2 Intra-Aortic Balloon Pump Catheters
3.4.1.3 Total Artificial Heart
3.4.1.4 Ventricular Assist Devices
3.4.2 Cardiac Valve Repair
3.4.3 Prosthetic Heart Valve
3.4.3.1 Mechanical Heart Valve
3.4.3.2 Tissue Heart Valve
3.5 Cardiovascular Surgery
3.5.1 Beating Heart Surgery Systems
3.5.2 Cardiac Ablation Devices
3.5.3 Cardiopulmonary Bypass Equipment
3.5.4 Perfusion Disposables
3.5.4.1 Custom Packs
3.5.4.2 Oxygenators
3.6 Electrophysiology
3.6.1 Electrophysiology Ablation Catheter
3.6.2 Electrophysiology Diagnostic Catheter
3.6.3 Electrophysiology Lab Systems
3.7 Interventional Cardiology
3.7.1 Arteriotomy Closure Devices
3.7.2 Cardiac Catheter
3.7.2.1 Angiography Catheter
3.7.2.2 Guiding Catheter
3.7.3 Coronary Guidewire
3.7.4 Coronary Stent
3.7.4.1 Bare Metal Stent
3.7.4.2 Drug Eluting Stent (DES)
3.7.5 PTCA Balloon
3.7.5.1 FW Balloon
3.7.5.2 Over the Wire Balloon
3.7.5.3 Rx Balloon
3.8 Peripheral Vascular Devices
3.8.1 Aortic Stent Graft
3.8.2 Embolic Protection Devices
3.8.3 Inferior Vena Cava Filter
3.8.4 Peripheral Guidewire
3.8.5 Peripheral Vascular Stent
3.8.6 PTA Balloon
3.8.7 Synthetic Surgical Grafts
4 Healthcare Sector Review
4.1 Healthcare Expenditure
4.2 Healthcare Infrastructure
4.3 Healthcare Policy
5 Regulation System
5.1 Medical Equipment Approval Process
5.1.1 Classification of medical devices
5.1.2 Conformity Assessment Process
5.1.2.1 Class I devices
5.1.2.2 Class IIa devices
5.1.2.3 Class IIb devices
5.2 Post Market Surveillance (PMS)
6 Pricing and Reimbursement
6.1 Pricing and Reimbursement Policies
7 Distribution Structure
8 Cardiovascular Devices In Spain
8.1 Cardiovascular Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015
8.2 Cardiovascular Devices, Spain, Overall Revenue ($ mn), 2000-2015
8.3 Cardiovascular Devices, Spain, Category Volume (Units), 2000-2015
8.4 Cardiovascular Devices, Spain, Company Share (2007-2008)
9 Cardiac Rhythm Management In Spain
9.1 Cardiac Rhythm Management Overall Revenue (2000-2015)
9.1.1 Cardiac Resynchronisation Therapy Overall Revenue (2000-2015)
9.1.2 Implantable Cardioverter Defibrillator Overall Revenue (2000-2015)
9.1.3 Pacemaker Overall Revenue (2000-2015)
9.2 Cardiac Rhythm Management Overall Volume (2000-2015)
9.2.1 Cardiac Resynchronisation Therapy Overall Volume (2000-2015)
9.2.2 Implantable Cardioverter Defibrillator Overall Volume (2000-2015)
9.2.3 Pacemaker Overall Volume (2000-2015)
9.3 Cardiac Rhythm Management Average Price (2000-2015)
9.4 Cardiac Rhythm Management Distribution Share (2007-2008)
9.5 Cardiac Rhythm Management, Spain, Company Share (2007-2008)
10 Cardiovascular Monitoring and Diagnostic Devices In Spain
10.1 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (2000-2015)
10.2 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2000-2015)
10.3 Cardiovascular Monitoring and Diagnostic Devices Average Price (2000-2015)
10.4 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2007-2008)
10.5 Cardiovascular Monitoring and Diagnostic Devices, Spain, Company Share (2007-2008)
11 Cardiovascular Prosthetic Devices In Spain
11.1 Cardiovascular Prosthetic Devices Overall Revenue (2000-2015)
11.1.1 Cardiac Assist Devices Overall Revenue (2000-2015)
11.1.2 Prosthetic Heart Valve Overall Revenue (2000-2015)
11.2 Cardiovascular Prosthetic Devices Overall Volume (2000-2015)
11.2.1 Cardiac Assist Devices Overall Volume (2000-2015)
11.2.2 Prosthetic Heart Valve Overall Volume (2000-2015)
11.3 Cardiovascular Prosthetic Devices Average Price (2000-2015)
11.4 Cardiovascular Prosthetic Devices Distribution Share (2007-2008)
11.5 Cardiovascular Prosthetic Devices, Spain, Company Share (2007-2008)
12 Cardiovascular Surgery In Spain
12.1 Cardiovascular Surgery Overall Revenue (2000-2015)
12.1.1 Perfusion Disposables Overall Revenue (2000-2015)
12.2 Cardiovascular Surgery Overall Volume (2000-2015)
12.2.1 Perfusion Disposables Overall Volume (2000-2015)
12.3 Cardiovascular Surgery Average Price (2000-2015)
12.4 Cardiovascular Surgery Distribution Share (2007-2008)
12.5 Cardiovascular Surgery, Spain, Company Share (2007-2008)
13 Electrophysiology In Spain
13.1 Electrophysiology Overall Revenue (2000-2015)
13.2 Electrophysiology Overall Volume (2000-2015)
13.3 Electrophysiology Average Price (2000-2015)
13.4 Electrophysiology Distribution Share (2007-2008)
13.5 Electrophysiology, Spain, Company Share (2007-2008)
14 Interventional Cardiology In Spain
14.1 Interventional Cardiology Overall Revenue (2000-2015)
14.1.1 Cardiac Catheter Overall Revenue (2000-2015)
14.1.2 Coronary Stent Overall Revenue (2000-2015)
14.1.3 PTCA Balloon Overall Revenue (2000-2015)
14.2 Interventional Cardiology Overall Volume (2000-2015)
14.2.1 Cardiac Catheter Overall Volume (2000-2015)
14.2.2 Coronary Stent Overall Volume (2000-2015)
14.2.3 PTCA Balloon Overall Volume (2000-2015)
14.3 Interventional Cardiology Average Price (2000-2015)
14.4 Interventional Cardiology Distribution Share (2007-2008)
14.5 Interventional Cardiology, Spain, Company Share (2007-2008)
15 Peripheral Vascular Devices In Spain
15.1 Peripheral Vascular Devices Overall Revenue (2000-2015)
15.2 Peripheral Vascular Devices Overall Volume (2000-2015)
15.3 Peripheral Vascular Devices Average Price (2000-2015)
15.4 Peripheral Vascular Devices Distribution Share (2007-2008)
15.5 Peripheral Vascular Devices, Spain, Company Share (2007-2008)
16 Overview of Key Companies in Spain Cardiovascular Devices Market
16.1 Boston Scientific Corporation
16.1.1 Company Overview
16.1.2 Value Chain Analysis
16.1.2.1 Manufacturing
16.1.2.2 Product Development
16.1.2.3 Sales and Marketing
16.1.3 Boston Scientific Corporation Pipeline Products
16.1.3.1 Boston Scientific Corporation Pipeline Products By Equipment Type
16.1.3.2 Boston Scientific Corporation Pipeline Products By Development Stage
16.1.3.3 Boston Scientific Corporation Pipeline Products By Therapy Area
16.1.3.4 Boston Scientific Corporation Pipeline Products By Clinical Trials
16.1.3.5 Boston Scientific Corporation Pipeline Products By News Summary
16.2 Medtronic, Inc.
16.2.1 Company Overview
16.2.2 Value Chain Analysis
16.2.2.1 Manufacturing
16.2.2.2 Product Development
16.2.2.3 Sales and Marketing
16.2.3 Medtronic, Inc. Pipeline Products
16.2.3.1 Medtronic, Inc. Pipeline Products By Equipment Type
16.2.3.2 Medtronic, Inc. Pipeline Products By Development Stage
16.2.3.3 Medtronic, Inc. Pipeline Products By Therapy Area
16.2.3.4 Medtronic, Inc. Pipeline Products By Clinical Trials
16.2.3.5 Medtronic, Inc. Pipeline Products By News Summary
16.3 Cordis Corporation
16.3.1 Company Overview
16.3.2 Cordis Corporation Pipeline Products
16.3.2.1 Cordis Corporation Pipeline Products By Equipment Type
16.3.2.2 Cordis Corporation Pipeline Products By Development Stage
16.3.2.3 Cordis Corporation Pipeline Products By Therapy Area
16.3.2.4 Cordis Corporation Pipeline Products By Clinical Trials
16.3.2.5 Cordis Corporation Pipeline Products By News Summary
16.4 Abbott Laboratories
16.4.1 Company Overview
16.4.2 Value Chain Analysis
16.4.2.1 Manufacturing
16.4.2.2 Product Development
16.4.2.3 Sales and Marketing
16.5 St. Jude Medical, Inc.
16.5.1 Company Overview
16.5.2 Value Chain Analysis
16.5.2.1 Manufacturing
16.5.2.2 Product Development
16.5.2.3 Sales and Marketing
16.5.3 St. Jude Medical Inc. Pipeline Products
16.5.3.1 St. Jude Medical Inc. Pipeline Products By Equipment Type
16.5.3.2 St. Jude Medical Inc. Pipeline Products By Development Stage
16.5.3.3 St. Jude Medical Inc. Pipeline Products By Therapy Area
16.5.3.4 St. Jude Medical Inc. Pipeline Products By Clinical Trials
16.5.3.5 St. Jude Medical Inc. Pipeline Products By News Summary
16.6 BIOTRONIK GmbH & Co. KG
16.6.1 Company Overview
16.6.2 BIOTRONIK GmbH & Co. KG Pipeline Products
16.6.2.1 BIOTRONIK GmbH & Co. KG Pipeline Products By Equipment Type
16.6.2.2 BIOTRONIK GmbH & Co. KG Pipeline Products By Development Stage
16.6.2.3 BIOTRONIK GmbH & Co. KG Pipeline Products By Therapy Area
16.6.2.4 BIOTRONIK GmbH & Co. KG Pipeline Products By Clinical Trials
16.6.2.5 BIOTRONIK GmbH & Co. KG Pipeline Products By News Summary
16.7 Sorin S.p.A.
16.7.1 Company Overview
16.7.2 Value Chain Analysis
16.7.2.1 Manufacturing
16.7.2.2 Product Development
16.7.2.3 Sales and Marketing
16.7.3 Sorin Group Pipeline Products
16.7.3.1 Sorin Group Pipeline Products By Equipment Type
16.7.3.2 Sorin Group Pipeline Products By Development Stage
16.7.3.3 Sorin Group Pipeline Products By Therapy Area
16.7.3.4 Sorin Group Pipeline Products By Clinical Trials
16.7.3.5 Sorin Group Pipeline Products By News Summary
16.8 GE Healthcare
16.8.1 Company Overview
16.8.2 GE Healthcare Pipeline Products
16.8.2.1 GE Healthcare Pipeline Products By Equipment Type
16.8.2.2 GE Healthcare Pipeline Products By Development Stage
16.8.2.3 GE Healthcare Pipeline Products By Therapy Area
16.8.2.4 GE Healthcare Pipeline Products By Clinical Trials
16.8.2.5 GE Healthcare Pipeline Products By News Summary
16.9 Philips Healthcare
16.9.1 Company Overview
16.9.2 Value Chain Analysis
16.9.2.1 Manufacturing
16.9.2.2 Product Development
16.9.2.3 Sales and Marketing
16.10 Cardiac Science Corporation
16.10.1 Company Overview
16.10.2 Value Chain Analysis
16.10.2.1 Manufacturing
16.10.2.2 Product Development
16.10.2.3 Sales and Marketing
16.11 Nihon Kohden Corporation
16.11.1 Company Overview
16.11.2 Value Chain Analysis
16.11.2.1 Manufacturing
16.11.2.2 Product Development
16.11.2.3 Sales and Marketing
16.12 Edwards Lifesciences Corporation
16.12.1 Company Overview
16.12.2 Value Chain Analysis
16.12.2.1 Manufacturing
16.12.2.2 Product Development
16.12.2.3 Sales and Marketing
16.12.3 Edwards Lifesciences Corporation Pipeline Products
16.12.3.1 Edwards Lifesciences Corporation Pipeline Products By Equipment Type
16.12.3.2 Edwards Lifesciences Corporation Pipeline Products By Development Stage
16.12.3.3 Edwards Lifesciences Corporation Pipeline Products By Therapy Area
16.12.3.4 Edwards Lifesciences Corporation Pipeline Products By Clinical Trials
16.12.3.5 Edwards Lifesciences Corporation Pipeline Products By News Summary
16.13 MAQUET GmbH & Co. KG
16.13.1 Company Overview
16.14 Terumo Corporation
16.14.1 Company Overview
16.14.2 Value Chain Analysis
16.14.2.1 Manufacturing
16.14.2.2 Product Development
16.14.2.3 Sales and Marketing
16.14.3 Terumo Corporation Pipeline Products
16.14.3.1 Terumo Corporation Pipeline Products By Equipment Type
16.14.3.2 Terumo Corporation Pipeline Products By Development Stage
16.14.3.3 Terumo Corporation Pipeline Products By Therapy Area
16.14.3.4 Terumo Corporation Pipeline Products By Clinical Trials
16.14.3.5 Terumo Corporation Pipeline Products By News Summary
16.15 AtriCure, Inc.
16.15.1 Company Overview
16.15.1.1 AtriCure, Inc. Pipeline Products
16.15.1.2 AtriCure, Inc. Pipeline Products By Equipment Type
16.15.1.3 AtriCure, Inc. Pipeline Products By Development Stage
16.15.1.4 AtriCure, Inc. Pipeline Products By Therapy Area
16.15.1.5 AtriCure, Inc. Pipeline Products By Clinical Trials
16.15.1.6 AtriCure, Inc. Pipeline Products By News Summary
16.16 ev3 Inc.
16.16.1 Company Overview
16.16.2 Value Chain Analysis
16.16.2.1 Manufacturing
16.16.2.2 Product Development
16.16.2.3 Sales and Marketing
16.16.3 ev3 Inc. Pipeline Products
16.16.3.1 ev3 Inc. Pipeline ProductsBy Equipment Type
16.16.3.2 ev3 Inc. Pipeline Products By Development Stage
16.16.3.3 ev3 Inc. Pipeline Products By Therapy Area
16.16.3.4 ev3 Inc. Pipeline Products By Clinical Trials
16.16.3.5 ev3 Inc. Pipeline Products By News Summary
16.17 OSI Systems, Inc.
16.17.1 Company Overview
16.17.2 Value Chain Analysis
16.17.2.1 Manufacturing
16.17.2.2 Product Development
16.17.2.3 Sales and Marketing
16.18 Datascope Corporation
16.18.1 Company Overview
16.18.2 Value Chain Analysis
16.18.2.1 Manufacturing
16.18.2.2 Product Development
16.18.2.3 Sales and Marketing
16.19 ABIOMED, Inc.
16.19.1 Company Overview
16.19.2 Value Chain Analysis
16.19.2.1 Manufacturing
16.19.2.2 Product Development
16.19.2.3 Sales and Marketing
16.19.3 ABIOMED, Inc. Pipeline Products
16.19.3.1 ABIOMED, Inc. Pipeline Products By Equipment Type
16.19.3.2 ABIOMED, Inc. Pipeline Products By Development Stage
16.19.3.3 ABIOMED, Inc. Pipeline Products By Therapy Area
16.19.3.4 ABIOMED, Inc. Pipeline Products By Clinical Trials
16.19.3.5 ABIOMED, Inc. Pipeline Products By News Summary
16.20 Thoratec Corporation
16.20.1 Company Overview
16.20.2 Value Chain Analysis
16.20.2.1 Manufacturing
16.20.2.2 Product Development
16.20.2.3 Sales and Marketing
16.20.2.4 Thoratec Corporation Pipeline Products
16.20.2.5 Thoratec Corporation Pipeline Products By Equipment Type
16.20.2.6 Thoratec Corporation Pipeline Products By Development Stage
16.20.2.7 Thoratec Corporation Pipeline Products By Therapy Area
16.20.2.8 Thoratec Corporation Pipeline Products By Clinical Trials
16.20.2.9 Thoratec Corporation Pipeline Products By News Summary
16.21 C.R. Bard, Inc.
16.21.1 Company Overview
16.21.2 Value Chain Analysis
16.21.2.1 Manufacturing
16.21.2.2 Product Development
16.21.2.3 Sales and Marketing
16.21.3 C.R. Bard, Inc. Pipeline Products
16.21.3.1 C.R. Bard, Inc. Pipeline Products By Equipment Type
16.21.3.2 C.R. Bard, Inc. Pipeline Products By Development Stage
16.21.3.3 C.R. Bard, Inc. Pipeline Products By Therapy Area
16.21.3.4 C.R. Bard, Inc. Pipeline Products By Clinical Trials
16.22 Arrow International, Inc.
16.22.1 Company Overview
16.22.2 Value Chain Analysis
16.22.2.1 Manufacturing
16.22.2.2 Product Development
16.22.2.3 Sales and Marketing
16.22.3 Arrow International, Inc. Pipeline Products
16.22.3.1 Arrow International, Inc. Pipeline Products By Equipment Type
16.22.3.2 Arrow International, Inc. Pipeline Products By Development Stage
16.22.3.3 Arrow International, Inc. Pipeline Products By Therapy Area
16.22.3.4 Arrow International, Inc. Pipeline Products By Clinical Trials
16.23 Invatec S.r.l.
16.23.1 Company Overview
16.23.2 Invatec S.r.l. Pipeline Products
16.23.2.1 Invatec S.r.l. Pipeline Products By Equipment Type
16.23.2.2 Invatec S.r.l. Pipeline Products By Development Stage
16.23.2.3 Invatec S.r.l. Pipeline Products By Therapy Area
16.23.2.4 Invatec S.r.l. Pipeline Products By Clinical Trials
16.23.2.5 Invatec S.r.l. Pipeline Products By News Summary
16.24 Fukuda Denshi Co., Ltd.
16.24.1 Company Overview
16.25 Welch Allyn Inc.
16.25.1 Company Overview
16.26 ST-Electromedicina, s.a
16.26.1 Company Overview
16.27 Biosense Webster, Inc.
16.27.1 Company Overview
17 Recent Developments
17.1 Product News
17.1.1 May 20, 2009: Treatment Of Complex Coronary Artery Disease With TAXUS Express2 Stent System Found To Be More Cost Effective Than Bypass Surgery In SYNTAX Analysis
17.1.2 May 19, 2009: Boston Scientific Announces Launch Of Third-Generation Platinum Chromium Drug-Eluting Stent In Select Markets
17.1.3 May 19, 2009: Cordis’ Nevo Sirolimus-Eluting Coronary Stent Shows Superior Results In Comparison To Taxus Liberte Stent
18 Appendix
18.1 Global Markets Direct Research Methodology
18.2 Coverage
18.3 Secondary Research
18.4 Primary Research
18.5 Models
18.6 Forecasts
18.7 Expert Panel Validation
18.8 Currency Conversion
18.9 Contact Us
18.10 Disclaimer
1.1 List of Tables
Table 1: Healthcare Expenditure in Japan, 2000 - 2005
Table 2: Number of Healthcare Institutions in Japan, 1995 - 2004
Table 3: Number of Hospital Beds in Japan, 1995 - 2004
Table 4: Number of Medical Personnel in Japan, 1995 - 2004
Table 5: Number of Doctors by Specialty in Japan, 2003-2007
Table 6: Number of Medical Care Institutions and Beds in Japan, 2000 - 2004
Table 7: Registration Processing Time for Medical Devices in Japan, 2007
Table 8: Product Registration Fee for Medical Devices in Japan, 2007
Table 9: Cardiovascular Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
Table 10: Cardiovascular Devices, Japan, Overall Revenue ($ mn), 2000-2015
Table 11: Cardiovascular Devices, Japan, Cross-Category Analysis, 2000-2015
Table 12: Cardiovascular Devices, Japan, Overall Revenue ($ mn), Historic, 2000-2008
Table 13: Cardiovascular Devices, Japan, Overall Revenue ($ mn), Forecast, 2008-2015
Table 14: Cardiovascular Devices, Japan, Category Volume (Units), 2000-2015
Table 15: Cardiovascular Devices, Japan, Category Volume (Units), Historic, 2000-2008
Table 16: Cardiovascular Devices, Japan, Category Volume (Units), Forecast, 2008-2015
Table 17: Cardiovascular Devices, Japan, Company Share by Revenue ($ mn), 2007-2008
Table 18: Cardiac Rhythm Management, Japan, Revenue ($ mn) by Segment, Historic, 2000-2008
Table 19: Cardiac Rhythm Management, Japan, Revenue ($ mn) by Segment, Forecast, 2008-2015
Table 20: Cardiac Resynchronisation Therapy, Japan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 21: Cardiac Resynchronisation Therapy, Japan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 22: Implantable Cardioverter Defibrillator, Japan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 23: Implantable Cardioverter Defibrillator, Japan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 24: Pacemaker, Japan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 25: Pacemaker, Japan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 26: Cardiac Rhythm Management, Japan, Volume (Units) by Segment, Historic, 2000-2008
Table 27: Cardiac Rhythm Management, Japan, Volume (Units) by Segment, Forecast, 2008-2015
Table 28: Cardiac Resynchronisation Therapy, Japan, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 29: Cardiac Resynchronisation Therapy, Japan, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 30: Implantable Cardioverter Defibrillator, Japan, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 31: Implantable Cardioverter Defibrillator, Japan, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 32: Pacemaker, Japan, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 33: Pacemaker, Japan, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 34: Cardiac Rhythm Management, Japan, Average Price ($), Historic, 2000-2008
Table 35: Cardiac Rhythm Management, Japan, Average Price ($), Forecast, 2008-2015
Table 36: Cardiac Rhythm Management, Japan, Distribution Share by Revenue ($mn), 2007-2008
Table 37: Cardiac Rhythm Management, Japan, Company Share by Revenue ($ mn), 2007-2008
Table 38: Cardiovascular Monitoring and Diagnostic Devices, Japan, Revenue ($ mn) by Segment, Historic, 2000-2008
Table 39: Cardiovascular Monitoring and Diagnostic Devices, Japan, Revenue ($ mn) by Segment, Forecast, 2008-2015
Table 40: Cardiovascular Monitoring and Diagnostic Devices, Japan, Volume (Units) by Segment, Historic, 2000-2008
Table 41: Cardiovascular Monitoring and Diagnostic Devices, Japan, Volume (Units) by Segment, Forecast, 2008-2015
Table 42: Cardiovascular Monitoring and Diagnostic Devices, Japan, Average Price ($), Historic, 2000-2008
Table 43: Cardiovascular Monitoring and Diagnostic Devices, Japan, Average Price ($), Forecast, 2008-2015
Table 44: Cardiovascular Monitoring and Diagnostic Devices, Japan, Distribution Share by Revenue ($mn), 2007-2008
Table 45: Cardiovascular Monitoring and Diagnostic Devices, Japan, Company Share by Revenue ($ mn), 2007-2008
Table 46: Cardiovascular Prosthetic Devices, Japan, Revenue ($ mn) by Segment, Historic, 2000-2008
Table 47: Cardiovascular Prosthetic Devices, Japan, Revenue ($ mn) by Segment, Forecast, 2008-2015
Table 48: Prosthetic Heart Valve, Japan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 49: Prosthetic Heart Valve, Japan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 50: Cardiovascular Prosthetic Devices, Japan, Volume (Units) by Segment, Historic, 2000-2008
Table 51: Cardiovascular Prosthetic Devices, Japan, Volume (Units) by Segment, Forecast, 2008-2015
Table 52: Prosthetic Heart Valve, Japan, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 53: Prosthetic Heart Valve, Japan, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 54: Cardiovascular Prosthetic Devices, Japan, Average Price ($), Historic, 2000-2008
Table 55: Cardiovascular Prosthetic Devices, Japan, Average Price ($), Forecast, 2008-2015
Table 56: Cardiovascular Prosthetic Devices, Japan, Distribution Share by Revenue ($mn), 2007-2008
Table 57: Cardiovascular Prosthetic Devices, Japan, Company Share by Revenue ($ mn), 2007-2008
Table 58: Cardiovascular Surgery, Japan, Revenue ($ mn) by Segment, Historic, 2000-2008
Table 59: Cardiovascular Surgery, Japan, Revenue ($ mn) by Segment, Forecast, 2008-2015
Table 60: Perfusion Disposables, Japan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 61: Perfusion Disposables, Japan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 62: Cardiovascular Surgery, Japan, Volume (Units) by Segment, Historic, 2000-2008
Table 63: Cardiovascular Surgery, Japan, Volume (Units) by Segment, Forecast, 2008-2015
Table 64: Perfusion Disposables, Japan, Volume (Units)
Order Form
       * Please reference product number R3480-13928 when ordering or inquiring.
PUBLICATION:   Japan Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015
QTY. FORMAT PRICE TOTAL
  Online Download$2,500.00   
  Global Site License$7,500.00   
  SUBTOTAL   
SHIPPING CHARGES
 (U.S. $25, Canada $35, Int'l $65) 		 
TOTAL  

CONTACT INFORMATION
PAYMENT INFORMATION
Name ____________________________________________ MasterCard VISA AmEx Discover

__________________________________
Account number                 Exp. date

__________________________________
Signature

__________________________________
Email

Please invoice
      (shipment on receipt of payment)
Payment enclosed
*CHECKS / WIRE TRANSFERS:
Checks must be paid in U.S. funds.
Please call for details.
Company ____________________________________________
Job Title ____________________________________________
Address ____________________________________________
City ____________________________________________
Company ____________________________________________
State ______________________________   Zip__________
Country ____________________________________________
Phone ____________________________________________
MindBranch, Inc.,     131 Ashland St., Suite 200 North Adams, MA  01247       tel: 800-774-4410     fax: +1-413-664-9791     www.mindbranch.com